跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 103 条关于
“DMAbs”
全部
103
临床试验
19
药物
72
机构
2
资讯
10
去年
INOVIO's DNA-Encoded Monoclonal Antibodies Show Durable 72-Week Expression Without Immune Rejection in COVID-19 Trial
11个月前
INOVIO's DNA-Encoded Antibody Platform Achieves 72-Week Sustained Expression in Phase 1 Trial
去年
Three Pharmaceutical Companies Advance Next-Generation COVID-19 Therapeutics in Clinical Trials
去年
Y-mAbs Announces Strategic Realignment and Positive Preliminary Data for SADA PRIT Platform
去年
Oppenheimer Predicts Significant Growth for Sagimet and Y-mAbs Therapeutics
去年
High-Concentration mAbs Present Manufacturing Challenges as Demand Surges, Reports CPHI Europe
4个月前
Y-mAbs Therapeutics Restructures Pipeline Following FDA Rejection of Neuroblastoma Drug Omburtamab
去年
Y-mAbs Presents Preclinical Pharmacokinetics Data for CD38-SADA Pretargeted Radioimmunotherapy at AACR 2025
去年
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million, Expanding Rare Oncology Portfolio
去年
Y-mAbs Initiates Phase 1 Trial of CD38-SADA Radioimmunotherapy for Relapsed Non-Hodgkin Lymphoma